| AROVELLA THERAPEUTICS |
| Australien |
| Gesundheit |
| AU0000182784 / A3C575 |
| E4NA (Frankfurt) |
| FRA:E4NA, ETR:E4NA, E4NA:GR |
| - |
| https://www.arovella.com/ |
|
Arovella Therapeutics Limited is a biotechnology company specializing in the development of cell therapies for cancer treatment. Its primary focus is on advancing an innovative platform based on invariant natural killer T (iNKT) cells, which are engi..
>Volltext.. |
| 50.53 Mio. EUR |
| 39.54 Mio. EUR |
| - |
| -6.7 Mio. EUR |
| -4.58 Mio. EUR |
| - |
| - |
| 11.19 Mio. EUR |
| -3.94 Mio. EUR |
| 15 |
| -100% |
| -20.33% |
| - |
| - |
| - |
| - |
| AROVELLA |
| 05.04.26 |
|